Concerning the Proposed Acquisition of Allergan plc by AbbVie Inc.

AbbVie Inc. (“AbbVie”), the seventh largest pharmaceutical company in the world by revenue, proposes to acquire Allergan plc (“Allergan”), ...

AbbVie Completes Transformative Acquisition of Allergan - May 8 ...

Under the terms of the transaction agreement, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan ...

AbbVie Inc. and Allergan plc, In the Matter of

and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would ...

AbbVie Inc. Completes Acquisition of Allergan plc

Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement ...

Allergan Shareholders Approve Proposed Acquisition by AbbVie

Allergan plc (NYSE: AGN) (the "Company" or "Allergan") today announced that its shareholders have voted to approve the previously announced ...

AbbVie and Allergan Receive Clearance from U.S. Federal Trade ...

As part of the proposed consent, Allergan has agreed to divest brazikumab, an investigational IL-23 inhibitor in development for autoimmune ...

AbbVie Inc. and Allergan plc; Analysis of Consent Order To Aid ...

The Consent Agreement eliminates the competitive concerns raised by the proposed Acquisition by requiring the combined company to divest ...

AbbVie to Acquire Allergan in Transformative Move for Both ...

On June 24, 2019, the AbbVie Board met, together with AbbVie's senior management and financial and legal advisors, to consider proposed terms ...

Commission approves AbbVie - Allergan merger

The European Commission has approved, under the EU Merger Regulation, the proposed acquisition of Allergan by AbbVie.

AbbVie Allergan Acquisition - Investor Presentation

... PROPOSED ACQUISITION. Allergan's ... stock or Allergan's ordinary shares and on AbbVie's or Allergan's operating results because.

EX-99.1 - SEC.gov

Allergan plc (NYSE: AGN) announced that following a hearing today before the Irish High Court it has scheduled shareholder meetings for Monday, October 14, 2019 ...

AbbVie completes acquisition of Allergan - PharmaTimes

AbbVie has wrapped up its $63 billion acquisition of Allergan plc following receipt of regulatory approval from all government authorities.

Abbvie to buy Allergan in $63bn deal - Financier Worldwide

Drug manufacturer Abbvie Inc is to acquire Irish rival Allergan Plc for around $63bn in a cash and stock transaction.

Three factors that drove the transformational integration of AbbVie ...

On May 8, 2020, the new AbbVie was created. That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, ...

EX-99.2 - SEC.gov

The proposed combination would expand global commercial and R&D scale to further enhance the value of Allergan's portfolio of fast-growing ...

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion - WSJ

The takeover is worth about $188 a share in cash and stock, the companies said. The price represents a 45% premium over Allergan's closing share ...

Allergan Shareholders Approve Proposed Acquisition by AbbVie

Under the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction ...

PRESS RELEASE - AbbVie

... Allergan plc or AbbVie Inc. may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013.

AbbVie Announces Extension of Expiration Date for Exchange ...

On the early participation date of November 7, 2019, requisite consents were received and supplemental indentures were executed eliminating ...

Allergan Shareholders Overwhelmingly Approve Acquisition by ...

... proposed acquisition of Allergan by AbbVie Inc. More than 99 percent ... AbbVie's common stock of $78.45 on June 24, 2019. Allergan ...